the aid library

LIST OPTIONS

Filter

1995

Sort by:

Direction:

Download (749)

View PDF (924)

National Guidelines for Prevention of Mother to Child Transmission of HIV (PMTCT)

Federal Ministry of Health, Dept. of Public Health, National HIVSTI (2010) C1

Download (231)

View PDF (346)

People living with HIV

M. Smelyanskaya, J. Duncan; C. Daniels, et al. Stop TB Partnership; The Focus Group Consulting (2017) C1

Key populations brief Accessed November 2017

Download (215)

View PDF (325)

Community-based TB and HIV integration

G. Mburu, D. Richardson PATH; Alliance (2013) C1

Good practice guide Supporting community action on HIV, health and rights to end AIDS

Download (620)

View PDF (828)

National HIV and AIDS , STI Policy

Ghana AIDS Commission (2013) C1

Download (644)

View PDF (2780)

2015 Pipeline Report HIV, Hepatitis C virus (HCV), and Tuberculosis (TB)

Polly Clayden, Simon Collins, Mike Frick, et al. A. Benzacar; HIV i-BASETREATMENT ACTION GROUP (2015)

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development

Download (1170)

View PDF (2605)

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
recommended

Dennis Falzon, Elizabeth Harausz, Ernesto Jaramillo et al. World Health Organization (WHO) (2016) C_WHO

Download (284)

View PDF (434)

South African Antimicrobial Resistance National Strategy Framework. A One Health Approach 2018 – 2024

Dept. of Health ; Dept of Agriculture, Forestry & Fisheries, South Africa (2018) C1

Download (185)

View PDF (168)

Childhood Tuberculosis: Diagnosis, Treatment and Prevention of TB in HIV-infected Children

C. DC Christie-Samuels World Health Organization (2019) C_WHO

Accessed: 21.10.2019

Download (856)

View PDF (1224)

Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 up-date

H. Schünemann, S.T. Aung, F. Bonsu et al. World Health Organisation (WHO) (2017) C_WHO

Download (745)

View PDF (2945)

Management of Buruli ulcer–HIV coinfection

World Health Organization WHO (2020) C_WHO

Technical Update Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection.... more

Download (279)

View PDF (478)

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

I. A. Vasilyeva Russian Ministry of Health (2017) C1

Accessed November 2017

Download (106)

View PDF (134)

Optimizing HIV Investments in Armenia

C. Hamelmann; M. Manova; E. Masaki; et al. Armenian National AIDS Center; The Global Fund; UNAIDS; UNDP; International Bank for Reconstruction and Development; et al. (2019) C2

Accessed: 29.09.2019

Download (819)

View PDF (1055)

The National Guidelines for the Management of HIV and AIDS in Children in Nepal

Government of Nepal, Ministry of Health and Population, National Centre for AIDS and STD Control (2008) CC

Download (748)

View PDF (1464)

Antiretroviral Therapy Guidelines for HIV-Infected Adults and Adolescents Including Post-exposure Prophylaxis

Ministry of Health & Family Welfare Government of India Ministry of Health & Family Welfare Government of India (2007) C1

Download (996)

View PDF (465)

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand

Weerawat Manosuthi, Sumet Ongwandee, Sorakij Bhakeecheep et al. (2015)

AIDS Research and Therapy 2015, 12:12 (24 April 2015)

Download (575)

View PDF (827)

National HIV and AIDS Priority Action Plan 2015/2016 - 2017/2018

Uganda AIDS Commission; Ministry of Health, Uganda (2015) C1

Download (113)

View PDF (127)

MILESTONES in the HIV epidemic among children and adolescents

UN Children's Fund UNICEF (2021) C_UNICEF

Milestones in the treatment, care and support, Dec 2021

Download (109)

View PDF (113)

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Zifodaya, J.; et al. Cochrane (2021) C1

Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.

Download (191)

View PDF (178)

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives more

Download (3)

View PDF (5)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update recommended

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
recommended